Abstract: The present invention relates to use of inhaled interferon-beta for use in preventing or reducing the severity of lower respiratory tract (LRT) illness in a patient infected with a coronavirus capable of causing acute respiratory distress syndrome, e.g. preventing or reducing the severity of LRT illness in COVID-19 patients infected with SARS-CoV-2. Targeting of such treatment to promote recovery based on simple and quick breathlessness scoring is proposed which is applicable in both the home and hospital environments.

Abstract: The present invention provides interferon-beta (IFN-?) for use in the treatment of virus-induced COPD exacerbations in patients treated with a systemic corticosteroid, wherein the IFN-? is administered by inhalation, e.g. by use of a nebuliser.

Abstract: A mounting arrangement for mounting a printer component to a support, using a foil including a number of mounting apertures, into which pins are inserted to provide alignment. The engagement of the pins in the aperture causes local deformation of the foil, the resulting forces acting to align the pins to an accuracy which can be greater than that to which the foil is manufactured.

Abstract: A drug package comprising a plurality of drug vials containing drugs for delivery to a patient in a drug delivery device; and a data carrier including drug treatment information for use by the drug delivery apparatus.

Abstract: A mounting arrangement for mounting a printer component to a support, using a foil including a number of mounting apertures, into which pins are inserted to provide alignment. The engagement of the pins in the aperture causes local deformation of the foil, the resulting forces acting to align the pins to an accuracy which can be greater than that to which the foil is manufactured.

Abstract: A drug package comprising a plurality of drug vials containing drugs for delivery to a patient in a drug delivery device; and a data carrier including drug treatment information for use by the drug delivery apparatus.

Abstract: A drug package comprising a plurality of drug vials containing drugs for delivery to a patient in a drug delivery device; and a data carrier including drug treatment information for use by the drug delivery apparatus.

Abstract: A print head for a continuous ink jet printer has a nozzle through which ink is emitted and broken up into droplets under the action of a piezoelectric oscillator. A charge electrode applies charge to selected droplets and a deflection electrode deflects the path of the charged droplets to cause printing on a substrate. A gutter collects droplets which are not required for printing. A charge electrode, together with one of the deflection electrodes is movable in a direction transverse to the path of the droplets selectively under the action of pressurized ink fed from an ink supply. Similarly, the gutter is movable in the same way by another actuator.

Abstract: A print head for a continuous ink jet printer has a nozzle 5 through which ink is emitted and broken up into droplets under the action of a piezoelectric oscillator. A charge electrode 3 applies charge to selected droplets and a deflection electrode 4 deflects the path 20 of the charged droplets to cause printing on a substrate. A gutter 6 collects droplets which are not required for printing. A charge electrode 3, together with one of the deflection electrodes 4 is movable in a direction transverse to the path of the droplets selectively under the action of pressurised ink fed from an ink supply 14. Similarly, the gutter 6 is movable in the same way.

Abstract: A small tablet containing over 90% by weight of an orally active cephalosporin such as cephalexin and which utilizes as a binder polyvinyl pyrrolidone having a number average molecular weight of from 500,000 to 1,500,000.